Ondine Biomedical has appointed Distrauma Medical SL to distribute its Steriwave™ nasal photodisinfection in Spain. The primary application for Steriwave nasal photodisinfection is nasal decolonization for the prevention of healthcare-associated infections, including surgical site infections. Steriwave can eliminate nasal bacteria, viruses, and fungi with a simple, 5-minute, non-antibiotic treatment.

The two-step process involvesthe application of a proprietary light-activated agent to each nostril using a nasal swab, followed by illumination of the area with a specific wavelength of laser light. The light activates the photodynamic agent, causing an oxidative burst that destroys all types of pathogens. A key benefit of this approach is that pathogens do not develop resistance to the therapy.

Steriwave has a CE mark for use in the EU and is approved in Canada, the UK, and several other countries.